Skip to main content
. 2022 Sep 27;2022(9):CD014638. doi: 10.1002/14651858.CD014638.pub2

1.4. Analysis.

1.4

Comparison 1: Dexrazoxane versus no dexrazoxane or placebo, Outcome 4: Cardiomyopathy/heart failure primary cause of death available‐case (best‐case and worst‐case identical results)